Keiko Minashi
0000-0003-1513-7117
Publication & Citation Trends
Publications
0 total
Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study.
Cited by 0
Semantic Scholar
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer
Cited by 0
Semantic Scholar
An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinoma
Cited by 0
Semantic Scholar
2117P Oncolytic virotherapy with suratadenoturev (OBP-301) injection with radiotherapy alone for esophageal cancer patients: Final results of OBP101JP study
Cited by 0
Semantic Scholar
Prognostic factors and treatment response in HER2-positive gastric cancer patients receiving trastuzumab deruxtecan: secondary analysis of the EN-DEAVOR study
Cited by 1
Semantic Scholar
214P A multicenter retrospective study of ramucirumab-containing chemotherapy for gastrointestinal neuroendocrine carcinoma after platinum-based chemotherapy (WJOG13420G: RAM-NEC)
Cited by 0
Semantic Scholar
500TiP An open label phase Ib/II study of trastuzumab deruxtecan (T-DXd) in combination with nivolumab and CAPOX for patients with HER2-low expressing gastroesophageal adenocarcinoma (EPOC2203)
Cited by 4
Semantic Scholar
1465P Potential impact of APC mutation on survival via immune evasion through WNT signaling activation in HER2-positive gastric cancer treated with trastuzumab (tmab), nivolumab (nivo), and chemotherapy
Cited by 0
Semantic Scholar
Research Topics
Gastric Cancer Management and Outcomes
(133)
Esophageal Cancer Research and Treatment
(97)
Esophageal and GI Pathology
(47)
Gastrointestinal Tumor Research and Treatment
(38)
Metastasis and carcinoma case studies
(31)
Affiliations
Chiba University
Gunma University
Kyorin University
Akita University
American Society for Gastrointestinal Endoscopy